| | | Quick Links | | | | | | | | | | | HIGHLIGHTS OF THE WEEK | December 31, 2010 - January 6, 2011 | | | | | | | | SPONSORED LINK Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc. FREE summary, plus donation to GAVI, or ACS Click Here! Receive FREE summary | | | | | | | Team expects to launch a test based on the IP-10 marker this year. Method is also capable of producing high yields of multiple AAV serotypes and efficient packaging. Next step is data analysis and interpretation of genetic regulation in cell proliferation. Genentech will tap Spirogen's technology and Pfizer will use Seattle Genetics'. Firm claims fundraising is largest ever in Europe by private biotech business. Roche/Genentech's mAb therapeutic raked in $5.6 billion in 2009 sales, and patents start expiring in 2014. It is hoped that the new client base in China will provide promising opportunities for Merck Millipore. French company projects that Phase IIb/III study with TG4010 will start later this year. Results challenge an evaluation of 14 studies that contradicted the initial discovery of this association. Pfizer is adding 10 more targets, which could draw $600 million in milestones. Acquired firm has over 2,800 products related to reference standards and materials. You can view more news broken down into over 90 categories and updated daily. Article from GEN's January 1 Issue | | The success rate in 2010 can be chalked up to the focus on cutting-edge technologies. | | | |
0 comments:
Post a Comment